Profile cover photo
Profile photo
Weitz & Luxenberg PC
70 followers -
Weitz & Luxenberg is the 2017 Law Firm of the Year for Mass Tort Litigation/Class Actions – Plaintiffs, says U.S. News & World Report.
Weitz & Luxenberg is the 2017 Law Firm of the Year for Mass Tort Litigation/Class Actions – Plaintiffs, says U.S. News & World Report.

70 followers
About
Posts

Post has attachment
Four talented attorneys recently joined the Mesothelioma and Asbestos Litigation unit in Weitz & Luxenberg’s growing New Jersey office. Welcome Michael Barry, Laura Laszewiski, Cody Greenes and James Wenzel!

https://www.weitzlux.com/firm-news/wls-new-jersey-office-welcomes-four-new-star-attorneys/

Post has attachment
Weitz & Luxenberg is accepting cases of patients who are experiencing complications or needed revision surgery because of a DePuy Synthes 4.5mm VA-LCP Curved Condylar Plate.

These devices are used to repair severe fractures of the distal femur where the bone has broken into multiple fragments.

https://www.weitzlux.com/firm-news/wl-accepting-clients-harmed-depuy-synthes-curved-condylar-plates/

Post has attachment
Weitz & Luxenberg is now accepting clients who were harmed by contaminated Sanofi Genzyme’s Synvisc-One arthritis gel. The gel is used as a treatment of osteoarthritis pain in the knee.

https://www.weitzlux.com/firm-news/wl-accepting-clients-harmed-recalled-contaminated-synvisc-one-arthritis-syringes/

Post has attachment

Post has attachment

Post has attachment
After a month-long trial, W&L has won a $20 million verdict on behalf of the family of the late Geoffrey Anisansel, a marine ship repairman who developed malignant mesothelioma after exposure to asbestos.

https://www.weitzlux.com/firm-news/wl-secures-20-million-verdict-family-mesothelioma-victim/

Post has attachment
Following reports of acute pancreatitis among people taking a type of diabetes medication, the U.S. Food and Drug Administration (FDA) said it is “evaluating the need for regulatory action” over the SGLT2 inhibitor class of drugs.

https://www.weitzlux.com/firm-news/fda-reviewing-sglt2-inhibitors-acute-pancreatitis-reports/

Post has attachment
The New York Law Journal has ranked Weitz & Luxenberg at the top of its annual list of leading verdicts and settlements, recognizing the firm for securing the highest Products Liability and Motor Vehicle verdicts of the past year. The rankings are determined by the monetary value of jury awards.

https://www.weitzlux.com/firm-news/wl-tops-new-york-law-journals-annual-ranking-verdicts-settlements-two-key-categories/

Post has attachment

Post has attachment
Wait while more posts are being loaded